Portfolio Holdings Detail for ISIN IE00BYVQ9F29
Stock Name / Fund iShares NASDAQ 100 UCITS ETF
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker NQSE(EUR) F
ETF Ticker NQSE.DE(EUR) CXE

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares NASDAQ 100 UCITS ETF REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-12-17 (Wednesday)	129,028	USD 96,743,904	USD 96,743,904	-48	USD 406,741	USD 749.79	USD 746.36
2025-12-16 (Tuesday)	129,076	USD 96,337,163	USD 96,337,163	-672	USD -1,313,777	USD 746.36	USD 752.62
2025-12-15 (Monday)	129,748	USD 97,650,940	USD 97,650,940	-540	USD 1,069,748	USD 752.62	USD 741.29
2025-12-12 (Friday)	130,288	USD 96,581,192	USD 96,581,192	-168	USD -843,349	USD 741.29	USD 746.8
2025-12-11 (Thursday)	130,456	USD 97,424,541	USD 97,424,541	-144	USD 2,581,515	USD 746.8	USD 726.21
2025-12-10 (Wednesday)	130,600	USD 94,843,026	USD 94,843,026	96	USD 3,064,783	USD 726.21	USD 703.26
2025-12-08 (Monday)	130,504	USD 91,778,243	USD 91,778,243	96	USD -1,901,648	USD 703.26	USD 718.36
2025-12-05 (Friday)	130,408	USD 93,679,891	USD 93,679,891	276	USD -379,519	USD 718.36	USD 722.8
2025-12-04 (Thursday)	130,132	USD 94,059,410	USD 94,059,410	312	USD 112,571	USD 722.8	USD 723.67
2025-12-03 (Wednesday)	129,820	USD 93,946,839	USD 93,946,839	336	USD -2,130,289	USD 723.67	USD 742
2025-12-02 (Tuesday)	129,484	USD 96,077,128	USD 96,077,128	12	USD -1,041,114	USD 742	USD 750.11
2025-12-01 (Monday)	129,472	USD 97,118,242	USD 97,118,242	-96	USD -3,969,416	USD 750.11	USD 780.19

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BYVQ9F29

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-17 SELL -48 751.990 743.330 744.196 USD -35,721 644.85 Loss of -4,769 on sale
2025-12-16 SELL -672 757.350 734.720 736.983 USD -495,253 644.43 Loss of -62,199 on sale
2025-12-15 SELL -540 756.660 746.375 747.403 USD -403,598 643.97 Loss of -55,854 on sale
2025-12-12 SELL -168 746.050 734.380 735.547 USD -123,572 643.56 Loss of -15,454 on sale
2025-12-11 SELL -144 753.565 726.455 729.166 USD -105,000 643.12 Loss of -12,390 on sale
2025-12-10 BUY 96 728.000 692.500 696.050 USD 66,821 642.77
2025-12-08 BUY 96 724.130 701.745 703.983 USD 67,582 642.51
2025-12-05 BUY 276 736.150 717.265 719.153 USD 198,486 642.18
2025-12-04 BUY 312 722.800* 641.84
2025-12-03 BUY 336 744.225 720.140 722.549 USD 242,776 641.48
2025-12-02 BUY 12 742.000* 641.05
2025-12-01 SELL -96 779.840 748.210 751.373 USD -72,132 640.57 Loss of -10,637 on sale
2025-11-28 BUY 48 780.190* 639.96
2025-11-26 BUY 48 790.980 777.000 778.398 USD 37,363 638.68
2025-11-26 BUY 48 790.980 777.000 778.398 USD 37,363 638.68
2025-11-25 BUY 24 790.570 760.700 763.687 USD 18,328 638.02
2025-11-24 BUY 12 773.130 756.640 758.289 USD 9,099 637.47
2025-11-21 BUY 48 755.900* 636.93
2025-11-20 BUY 216 737.000* 636.48
2025-11-19 SELL -12 702.750* 636.18 Profit of 7,634 on sale
2025-11-18 SELL -324 725.340* 635.78 Profit of 205,992 on sale
2025-11-17 SELL -132 711.880 692.290 694.249 USD -91,641 635.47 Loss of -7,759 on sale
2025-11-14 SELL -120 699.270 686.000 687.327 USD -82,479 635.20 Loss of -6,255 on sale
2025-11-13 BUY 24 713.580 679.930 683.295 USD 16,399 634.92
2025-11-07 BUY 60 657.530* 634.32
2025-11-06 SELL -24 657.000 641.260 642.834 USD -15,428 634.26 Loss of -206 on sale
2025-11-04 BUY 96 646.221 625.140 627.248 USD 60,216 634.24
2025-11-03 BUY 96 657.460 627.500 630.496 USD 60,528 634.20
2025-10-31 SELL -1,871 659.760 645.000 646.476 USD -1,209,557 634.12 Loss of -23,119 on sale
2025-10-30 BUY 324 664.000 645.000 646.900 USD 209,596 634.02
2025-10-29 BUY 252 652.910 659.980 659.273 USD 166,137 633.93
2025-10-28 BUY 192 654.480 655.700 655.578 USD 125,871 633.83
2025-10-27 SELL -96 585.310 586.150 586.066 USD -56,262 634.07 Profit of 4,608 on sale
2025-10-24 BUY 36 577.950 582.700 582.225 USD 20,960 634.35
2025-10-23 SELL -96 575.690 584.000 583.169 USD -55,984 634.64 Profit of 4,941 on sale
2025-10-22 BUY 72 584.740 588.710 588.313 USD 42,359 634.88
2025-10-21 BUY 108 579.340 582.410 582.103 USD 62,867 635.16
2025-10-20 SELL -360 576.770 582.650 582.062 USD -209,542 635.46 Profit of 19,222 on sale
2025-10-17 SELL -36 578.050 579.040 578.941 USD -20,842 635.75 Profit of 2,045 on sale
2025-10-16 BUY 96 569.170 589.080 587.089 USD 56,361 636.08
2025-10-14 SELL -84 572.600 576.180 575.822 USD -48,369 636.71 Profit of 5,115 on sale
2025-10-07 BUY 216 583.240 591.450 590.629 USD 127,576 636.99
2025-10-06 BUY 72 585.480 603.650 601.833 USD 43,332 637.26
2025-10-03 BUY 12 600.000 618.010 616.209 USD 7,395 637.45
2025-10-02 BUY 300 600.000 605.410 604.869 USD 181,461 637.65
2025-10-01 BUY 96 599.940 615.390 613.845 USD 58,929 637.85
2025-09-30 BUY 48 562.270 574.040 572.863 USD 27,497 638.25
2025-09-29 BUY 72 560.750 564.910 564.494 USD 40,644 638.66
2025-09-26 BUY 36 563.900 564.610 564.539 USD 20,323 639.06
2025-09-25 BUY 36 555.510 579.000 576.651 USD 20,759 639.51
2025-09-24 BUY 612 576.980 577.980 577.880 USD 353,663 639.85
2025-09-18 BUY 300 598.710 600.000 599.871 USD 179,961 640.07
2025-09-17 BUY 372 585.500 587.670 587.453 USD 218,533 640.37
2025-09-16 BUY 144 575.060 579.400 578.966 USD 83,371 640.73
2025-09-15 BUY 120 572.590 573.690 573.580 USD 68,830 641.10
2025-09-11 BUY 96 568.200 570.760 570.504 USD 54,768 641.96
2025-09-08 BUY 96 558.440 571.200 569.924 USD 54,713 643.41
2025-09-04 SELL -84 567.220 581.980 580.504 USD -48,762 644.25 Profit of 5,355 on sale
2025-08-22 SELL -12 589.480 610.450 608.353 USD -7,300 644.57 Profit of 435 on sale
2025-08-21 SELL -48 598.160 605.180 604.478 USD -29,015 644.84 Profit of 1,937 on sale
2025-08-20 BUY 36 591.010 596.920 596.329 USD 21,468 645.15
2025-08-19 BUY 120 571.780 581.690 580.699 USD 69,684 645.59
2025-07-31 SELL -1,775 545.460 558.130 556.863 USD -988,432 646.61 Profit of 159,297 on sale
2025-07-30 BUY 96 554.580 563.590 562.689 USD 54,018 647.16
2025-07-28 BUY 96 558.630 567.950 567.018 USD 54,434 648.23
2025-07-24 SELL -784 564.640 577.730 576.421 USD -451,914 649.27 Profit of 57,114 on sale
2025-07-23 SELL -196 572.390 576.700 576.269 USD -112,949 649.74 Profit of 14,401 on sale
2025-07-18 BUY 147 542.520 550.890 550.053 USD 80,858 650.97
2025-07-17 SELL -147 550.000 554.480 554.032 USD -81,443 651.60 Profit of 14,343 on sale
2025-07-15 BUY 49 547.960 574.750 572.071 USD 28,031 652.93
2025-07-14 BUY 49 570.590 575.130 574.676 USD 28,159 653.45
2025-07-11 BUY 49 567.740 568.460 568.388 USD 27,851 654.01
2025-07-10 BUY 98 559.760 566.370 565.709 USD 55,439 654.62
2025-07-09 BUY 98 552.580 558.380 557.800 USD 54,664 655.28
2025-07-08 SELL -49 547.750 559.460 558.289 USD -27,356 655.99 Profit of 4,787 on sale
2025-07-02 SELL -49 547.740 551.500 551.124 USD -27,005 658.99 Profit of 5,285 on sale
2025-07-01 BUY 294 534.910 548.040 546.727 USD 160,738 659.83
2025-06-30 BUY 392 525.000 526.080 525.972 USD 206,181 660.76
2025-06-26 BUY 294 521.000 524.520 524.168 USD 154,105 662.70
2025-06-25 BUY 484 520.290 525.630 525.096 USD 254,146 663.69
2025-06-24 BUY 98 522.270 527.450 526.932 USD 51,639 664.69
2025-06-23 SELL -49 511.920 516.180 515.754 USD -25,272 665.77 Profit of 7,351 on sale
2025-06-20 SELL -49 509.720 521.310 520.151 USD -25,487 666.89 Profit of 7,190 on sale
2025-06-18 BUY 96 513.580 519.170 518.611 USD 49,787 669.11
2025-06-17 BUY 49 508.860 523.010 521.595 USD 25,558 670.28
2025-06-16 SELL -240 522.680 538.200 536.648 USD -128,796 671.36 Profit of 32,332 on sale
2025-06-13 BUY 49 529.240 529.550 529.519 USD 25,946 672.42
2025-06-12 SELL -196 521.840 525.220 524.882 USD -102,877 673.54 Profit of 29,137 on sale
2025-06-06 BUY 49 493.220 499.880 499.214 USD 24,461 678.47
2025-06-05 BUY 96 483.070 491.770 490.900 USD 47,126 679.99
2025-06-04 BUY 98 484.930 499.900 498.403 USD 48,843 681.51
2025-06-03 BUY 1,176 487.860 501.110 499.785 USD 587,747 683.04
2025-06-02 BUY 49 490.810 502.560 501.385 USD 24,568 684.56
2025-05-30 BUY 194 490.280 519.780 516.830 USD 100,265 686.12
2025-05-29 SELL -49 605.390 605.730 605.696 USD -29,679 686.77 Profit of 3,972 on sale
2025-05-28 SELL -49 591.850 606.000 604.585 USD -29,625 687.54 Profit of 4,065 on sale
2025-05-23 SELL -98 588.340 591.640 591.310 USD -57,948 689.89 Profit of 9,661 on sale
2025-05-22 SELL -392 596.850 605.500 604.635 USD -237,017 690.68 Profit of 33,728 on sale
2025-05-20 SELL -48 614.790 615.450 615.384 USD -29,538 692.06 Profit of 3,680 on sale
2025-05-19 BUY 96 596.540 598.560 598.358 USD 57,442 692.88
2025-05-16 SELL -1,903 594.320 595.190 595.103 USD -1,132,481 693.74 Profit of 187,708 on sale
2025-05-15 BUY 441 584.990 585.260 585.233 USD 258,088 694.69
2025-05-14 BUY 98 571.360 580.560 579.640 USD 56,805 695.79
2025-05-13 BUY 441 574.160 575.050 574.961 USD 253,558 696.87
2025-05-12 BUY 343 575.630 577.990 577.754 USD 198,170 697.96
2025-05-08 BUY 147 547.670 552.570 552.080 USD 81,156 700.90
2025-05-02 BUY 98 605.610 615.610 614.610 USD 60,232 705.43
2025-04-29 BUY 196 568.910 579.980 578.873 USD 113,459 708.94
2025-04-28 BUY 343 610.860 614.830 614.433 USD 210,751 709.92
2025-04-25 BUY 147 602.640 602.790 602.775 USD 88,608 710.99
2025-04-24 BUY 98 599.760 601.280 601.128 USD 58,911 712.11
2025-04-23 BUY 98 587.850 603.770 602.178 USD 59,013 713.38
2025-04-22 BUY 343 585.490 587.100 586.939 USD 201,320 714.70
2025-04-16 BUY 98 549.280 561.830 560.575 USD 54,936 721.38
2025-04-15 BUY 245 557.910 575.200 573.471 USD 140,500 723.16
2025-04-14 BUY 588 571.060 574.720 574.354 USD 337,720 724.83
2025-04-11 BUY 200 554.180 555.530 555.395 USD 111,079 726.73
2025-04-09 BUY 550 576.720 580.730 580.329 USD 319,181 730.48
2025-04-08 BUY 1,000 556.810 586.030 583.108 USD 583,108 732.48
2025-04-04 SELL -650 573.450 612.990 609.036 USD -395,873 736.23 Profit of 82,674 on sale
2025-04-02 SELL -50 625.600 628.000 627.760 USD -31,388 737.54 Profit of 5,489 on sale
2025-04-01 SELL -50 617.000 641.240 638.816 USD -31,941 739.00 Profit of 5,009 on sale
2025-03-31 SELL -344 634.230 640.720 640.071 USD -220,184 740.27 Profit of 34,470 on sale
2025-03-26 BUY 444 640.140 644.000 643.614 USD 285,765 744.17
2025-03-25 BUY 547 634.140 662.570 659.727 USD 360,871 745.58
2025-03-24 BUY 150 661.000 667.460 666.814 USD 100,022 746.68
2025-03-21 BUY 50 658.480 661.000 660.748 USD 33,037 747.84
2025-03-20 BUY 100 662.620 674.830 673.609 USD 67,361 748.97
2025-03-19 BUY 391 672.360 674.570 674.349 USD 263,670 750.01
2025-03-18 BUY 100 664.960 678.270 676.939 USD 67,694 751.17
2025-03-17 SELL -150 678.420 679.830 679.689 USD -101,953 752.18 Profit of 10,874 on sale
2025-03-14 BUY 250 666.870 686.980 684.969 USD 171,242 753.38
2025-03-13 BUY 100 680.610 698.950 697.116 USD 69,712 754.42
2025-03-11 SELL -280 718.160 747.700 744.746 USD -208,529 755.91 Profit of 3,126 on sale
2025-03-10 SELL -250 744.830 748.290 747.944 USD -186,986 756.08 Profit of 2,033 on sale
2025-03-06 SELL -250 698.440 701.000 700.744 USD -175,186 757.71 Profit of 14,242 on sale
2025-03-05 SELL -100 687.150 692.790 692.226 USD -69,223 758.81 Profit of 6,659 on sale
2025-03-04 SELL -450 675.490 697.460 695.263 USD -312,868 760.14 Profit of 29,193 on sale
2025-03-03 SELL -235 684.870 704.640 702.663 USD -165,126 761.35 Profit of 13,792 on sale
2025-02-28 SELL -145 698.740 708.580 707.596 USD -102,601 762.38 Profit of 7,943 on sale
2025-02-25 SELL -200 723.470 739.000 737.447 USD -147,489 765.03 Profit of 5,517 on sale
2025-02-20 SELL -100 696.020 703.140 702.428 USD -70,243 768.40 Profit of 6,598 on sale
2025-02-19 SELL -300 685.660 688.670 688.369 USD -206,511 769.94 Profit of 24,470 on sale
2025-02-18 SELL -150 680.000 689.950 688.955 USD -103,343 771.63 Profit of 12,402 on sale
2025-02-13 BUY 100 674.270 677.690 677.348 USD 67,735 777.50
2025-02-07 BUY 100 710.000 731.420 729.278 USD 72,928 785.77
2025-01-29 BUY 200 687.270 697.570 696.540 USD 139,308 802.55
2025-01-28 BUY 50 686.330 690.300 689.903 USD 34,495 805.61
2025-01-27 SELL -5 684.710 698.450 697.076 USD -3,485 808.87 Profit of 559 on sale
2025-01-24 BUY 150 675.790 693.840 692.035 USD 103,805 812.57
2025-01-23 SELL -2,100 694.640 696.190 696.035 USD -1,461,674 815.94 Profit of 251,800 on sale
2025-01-02 BUY 3,212 715.190 726.810 725.648 USD 2,330,781 818.90
2024-12-10 BUY 49 778.500 791.490 790.191 USD 38,719 820.13
2024-12-09 SELL -343 788.000 800.990 799.691 USD -274,294 821.13 Profit of 7,354 on sale
2024-12-06 BUY 196 778.000 778.120 778.108 USD 152,509 822.52
2024-12-05 BUY 49 767.900 768.020 768.008 USD 37,632 824.34
2024-12-03 SELL -196 749.570 770.000 767.957 USD -150,520 829.52 Profit of 12,066 on sale
2024-12-02 BUY 98 762.340 763.890 763.735 USD 74,846 832.00
2024-11-29 BUY 144 750.220 754.510 754.081 USD 108,588 835.15
2024-11-27 BUY 98 754.870 762.160 761.431 USD 74,620 841.84
2024-11-26 BUY 49 753.030 754.180 754.065 USD 36,949 845.70
2024-11-22 BUY 150 738.000 751.400 750.060 USD 112,509 855.41
2024-11-21 BUY 49 744.500 757.560 756.254 USD 37,056 860.96
2024-11-19 BUY 147 744.600 758.600 757.200 USD 111,308 873.95
2024-11-18 SELL -507 762.000 762.700 762.630 USD -386,653 880.54 Profit of 59,780 on sale
2024-11-12 BUY 196 821.000 831.000 830.000 USD 162,680 884.26
2024-11-08 BUY 49 828.420 830.730 830.499 USD 40,694 892.43
2024-11-07 BUY 1,225 824.480 832.530 831.725 USD 1,018,863 897.66
2024-11-06 BUY 147 816.650 844.510 841.724 USD 123,733 904.41
2024-11-05 BUY 49 829.430 836.630 835.910 USD 40,960 911.23
2024-11-04 BUY 98 828.840 852.010 849.693 USD 83,270 919.47
2024-10-25 BUY 98 933.020 943.830 942.749 USD 92,389 950.28
2024-10-24 SELL -98 928.900 952.020 949.708 USD -93,071 957.41 Profit of 755 on sale
2024-10-21 BUY 147 968.500 991.240 988.966 USD 145,378 0.00
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-17	SELL	-48	751.990	743.330	744.196	USD -35,721	644.85 Loss of -4,769 on sale
2025-12-16	SELL	-672	757.350	734.720	736.983	USD -495,253	644.43 Loss of -62,199 on sale
2025-12-15	SELL	-540	756.660	746.375	747.403	USD -403,598	643.97 Loss of -55,854 on sale
2025-12-12	SELL	-168	746.050	734.380	735.547	USD -123,572	643.56 Loss of -15,454 on sale
2025-12-11	SELL	-144	753.565	726.455	729.166	USD -105,000	643.12 Loss of -12,390 on sale
2025-12-10	BUY	96	728.000	692.500	696.050	USD 66,821	642.77
2025-12-08	BUY	96	724.130	701.745	703.983	USD 67,582	642.51
2025-12-05	BUY	276	736.150	717.265	719.153	USD 198,486	642.18
2025-12-04	BUY	312			722.800*		641.84
2025-12-03	BUY	336	744.225	720.140	722.549	USD 242,776	641.48
2025-12-02	BUY	12			742.000*		641.05
2025-12-01	SELL	-96	779.840	748.210	751.373	USD -72,132	640.57 Loss of -10,637 on sale
2025-11-28	BUY	48			780.190*		639.96
2025-11-26	BUY	48	790.980	777.000	778.398	USD 37,363	638.68
2025-11-26	BUY	48	790.980	777.000	778.398	USD 37,363	638.68
2025-11-25	BUY	24	790.570	760.700	763.687	USD 18,328	638.02
2025-11-24	BUY	12	773.130	756.640	758.289	USD 9,099	637.47
2025-11-21	BUY	48			755.900*		636.93
2025-11-20	BUY	216			737.000*		636.48
2025-11-19	SELL	-12			702.750*		636.18 Profit of 7,634 on sale
2025-11-18	SELL	-324			725.340*		635.78 Profit of 205,992 on sale
2025-11-17	SELL	-132	711.880	692.290	694.249	USD -91,641	635.47 Loss of -7,759 on sale
2025-11-14	SELL	-120	699.270	686.000	687.327	USD -82,479	635.20 Loss of -6,255 on sale
2025-11-13	BUY	24	713.580	679.930	683.295	USD 16,399	634.92
2025-11-07	BUY	60			657.530*		634.32
2025-11-06	SELL	-24	657.000	641.260	642.834	USD -15,428	634.26 Loss of -206 on sale
2025-11-04	BUY	96	646.221	625.140	627.248	USD 60,216	634.24
2025-11-03	BUY	96	657.460	627.500	630.496	USD 60,528	634.20
2025-10-31	SELL	-1,871	659.760	645.000	646.476	USD -1,209,557	634.12 Loss of -23,119 on sale
2025-10-30	BUY	324	664.000	645.000	646.900	USD 209,596	634.02
2025-10-29	BUY	252	652.910	659.980	659.273	USD 166,137	633.93
2025-10-28	BUY	192	654.480	655.700	655.578	USD 125,871	633.83
2025-10-27	SELL	-96	585.310	586.150	586.066	USD -56,262	634.07 Profit of 4,608 on sale
2025-10-24	BUY	36	577.950	582.700	582.225	USD 20,960	634.35
2025-10-23	SELL	-96	575.690	584.000	583.169	USD -55,984	634.64 Profit of 4,941 on sale
2025-10-22	BUY	72	584.740	588.710	588.313	USD 42,359	634.88
2025-10-21	BUY	108	579.340	582.410	582.103	USD 62,867	635.16
2025-10-20	SELL	-360	576.770	582.650	582.062	USD -209,542	635.46 Profit of 19,222 on sale
2025-10-17	SELL	-36	578.050	579.040	578.941	USD -20,842	635.75 Profit of 2,045 on sale
2025-10-16	BUY	96	569.170	589.080	587.089	USD 56,361	636.08
2025-10-14	SELL	-84	572.600	576.180	575.822	USD -48,369	636.71 Profit of 5,115 on sale
2025-10-07	BUY	216	583.240	591.450	590.629	USD 127,576	636.99
2025-10-06	BUY	72	585.480	603.650	601.833	USD 43,332	637.26
2025-10-03	BUY	12	600.000	618.010	616.209	USD 7,395	637.45
2025-10-02	BUY	300	600.000	605.410	604.869	USD 181,461	637.65
2025-10-01	BUY	96	599.940	615.390	613.845	USD 58,929	637.85
2025-09-30	BUY	48	562.270	574.040	572.863	USD 27,497	638.25
2025-09-29	BUY	72	560.750	564.910	564.494	USD 40,644	638.66
2025-09-26	BUY	36	563.900	564.610	564.539	USD 20,323	639.06
2025-09-25	BUY	36	555.510	579.000	576.651	USD 20,759	639.51
2025-09-24	BUY	612	576.980	577.980	577.880	USD 353,663	639.85
2025-09-18	BUY	300	598.710	600.000	599.871	USD 179,961	640.07
2025-09-17	BUY	372	585.500	587.670	587.453	USD 218,533	640.37
2025-09-16	BUY	144	575.060	579.400	578.966	USD 83,371	640.73
2025-09-15	BUY	120	572.590	573.690	573.580	USD 68,830	641.10
2025-09-11	BUY	96	568.200	570.760	570.504	USD 54,768	641.96
2025-09-08	BUY	96	558.440	571.200	569.924	USD 54,713	643.41
2025-09-04	SELL	-84	567.220	581.980	580.504	USD -48,762	644.25 Profit of 5,355 on sale
2025-08-22	SELL	-12	589.480	610.450	608.353	USD -7,300	644.57 Profit of 435 on sale
2025-08-21	SELL	-48	598.160	605.180	604.478	USD -29,015	644.84 Profit of 1,937 on sale
2025-08-20	BUY	36	591.010	596.920	596.329	USD 21,468	645.15
2025-08-19	BUY	120	571.780	581.690	580.699	USD 69,684	645.59
2025-07-31	SELL	-1,775	545.460	558.130	556.863	USD -988,432	646.61 Profit of 159,297 on sale
2025-07-30	BUY	96	554.580	563.590	562.689	USD 54,018	647.16
2025-07-28	BUY	96	558.630	567.950	567.018	USD 54,434	648.23
2025-07-24	SELL	-784	564.640	577.730	576.421	USD -451,914	649.27 Profit of 57,114 on sale
2025-07-23	SELL	-196	572.390	576.700	576.269	USD -112,949	649.74 Profit of 14,401 on sale
2025-07-18	BUY	147	542.520	550.890	550.053	USD 80,858	650.97
2025-07-17	SELL	-147	550.000	554.480	554.032	USD -81,443	651.60 Profit of 14,343 on sale
2025-07-15	BUY	49	547.960	574.750	572.071	USD 28,031	652.93
2025-07-14	BUY	49	570.590	575.130	574.676	USD 28,159	653.45
2025-07-11	BUY	49	567.740	568.460	568.388	USD 27,851	654.01
2025-07-10	BUY	98	559.760	566.370	565.709	USD 55,439	654.62
2025-07-09	BUY	98	552.580	558.380	557.800	USD 54,664	655.28
2025-07-08	SELL	-49	547.750	559.460	558.289	USD -27,356	655.99 Profit of 4,787 on sale
2025-07-02	SELL	-49	547.740	551.500	551.124	USD -27,005	658.99 Profit of 5,285 on sale
2025-07-01	BUY	294	534.910	548.040	546.727	USD 160,738	659.83
2025-06-30	BUY	392	525.000	526.080	525.972	USD 206,181	660.76
2025-06-26	BUY	294	521.000	524.520	524.168	USD 154,105	662.70
2025-06-25	BUY	484	520.290	525.630	525.096	USD 254,146	663.69
2025-06-24	BUY	98	522.270	527.450	526.932	USD 51,639	664.69
2025-06-23	SELL	-49	511.920	516.180	515.754	USD -25,272	665.77 Profit of 7,351 on sale
2025-06-20	SELL	-49	509.720	521.310	520.151	USD -25,487	666.89 Profit of 7,190 on sale
2025-06-18	BUY	96	513.580	519.170	518.611	USD 49,787	669.11
2025-06-17	BUY	49	508.860	523.010	521.595	USD 25,558	670.28
2025-06-16	SELL	-240	522.680	538.200	536.648	USD -128,796	671.36 Profit of 32,332 on sale
2025-06-13	BUY	49	529.240	529.550	529.519	USD 25,946	672.42
2025-06-12	SELL	-196	521.840	525.220	524.882	USD -102,877	673.54 Profit of 29,137 on sale
2025-06-06	BUY	49	493.220	499.880	499.214	USD 24,461	678.47
2025-06-05	BUY	96	483.070	491.770	490.900	USD 47,126	679.99
2025-06-04	BUY	98	484.930	499.900	498.403	USD 48,843	681.51
2025-06-03	BUY	1,176	487.860	501.110	499.785	USD 587,747	683.04
2025-06-02	BUY	49	490.810	502.560	501.385	USD 24,568	684.56
2025-05-30	BUY	194	490.280	519.780	516.830	USD 100,265	686.12
2025-05-29	SELL	-49	605.390	605.730	605.696	USD -29,679	686.77 Profit of 3,972 on sale
2025-05-28	SELL	-49	591.850	606.000	604.585	USD -29,625	687.54 Profit of 4,065 on sale
2025-05-23	SELL	-98	588.340	591.640	591.310	USD -57,948	689.89 Profit of 9,661 on sale
2025-05-22	SELL	-392	596.850	605.500	604.635	USD -237,017	690.68 Profit of 33,728 on sale
2025-05-20	SELL	-48	614.790	615.450	615.384	USD -29,538	692.06 Profit of 3,680 on sale
2025-05-19	BUY	96	596.540	598.560	598.358	USD 57,442	692.88
2025-05-16	SELL	-1,903	594.320	595.190	595.103	USD -1,132,481	693.74 Profit of 187,708 on sale
2025-05-15	BUY	441	584.990	585.260	585.233	USD 258,088	694.69
2025-05-14	BUY	98	571.360	580.560	579.640	USD 56,805	695.79
2025-05-13	BUY	441	574.160	575.050	574.961	USD 253,558	696.87
2025-05-12	BUY	343	575.630	577.990	577.754	USD 198,170	697.96
2025-05-08	BUY	147	547.670	552.570	552.080	USD 81,156	700.90
2025-05-02	BUY	98	605.610	615.610	614.610	USD 60,232	705.43
2025-04-29	BUY	196	568.910	579.980	578.873	USD 113,459	708.94
2025-04-28	BUY	343	610.860	614.830	614.433	USD 210,751	709.92
2025-04-25	BUY	147	602.640	602.790	602.775	USD 88,608	710.99
2025-04-24	BUY	98	599.760	601.280	601.128	USD 58,911	712.11
2025-04-23	BUY	98	587.850	603.770	602.178	USD 59,013	713.38
2025-04-22	BUY	343	585.490	587.100	586.939	USD 201,320	714.70
2025-04-16	BUY	98	549.280	561.830	560.575	USD 54,936	721.38
2025-04-15	BUY	245	557.910	575.200	573.471	USD 140,500	723.16
2025-04-14	BUY	588	571.060	574.720	574.354	USD 337,720	724.83
2025-04-11	BUY	200	554.180	555.530	555.395	USD 111,079	726.73
2025-04-09	BUY	550	576.720	580.730	580.329	USD 319,181	730.48
2025-04-08	BUY	1,000	556.810	586.030	583.108	USD 583,108	732.48
2025-04-04	SELL	-650	573.450	612.990	609.036	USD -395,873	736.23 Profit of 82,674 on sale
2025-04-02	SELL	-50	625.600	628.000	627.760	USD -31,388	737.54 Profit of 5,489 on sale
2025-04-01	SELL	-50	617.000	641.240	638.816	USD -31,941	739.00 Profit of 5,009 on sale
2025-03-31	SELL	-344	634.230	640.720	640.071	USD -220,184	740.27 Profit of 34,470 on sale
2025-03-26	BUY	444	640.140	644.000	643.614	USD 285,765	744.17
2025-03-25	BUY	547	634.140	662.570	659.727	USD 360,871	745.58
2025-03-24	BUY	150	661.000	667.460	666.814	USD 100,022	746.68
2025-03-21	BUY	50	658.480	661.000	660.748	USD 33,037	747.84
2025-03-20	BUY	100	662.620	674.830	673.609	USD 67,361	748.97
2025-03-19	BUY	391	672.360	674.570	674.349	USD 263,670	750.01
2025-03-18	BUY	100	664.960	678.270	676.939	USD 67,694	751.17
2025-03-17	SELL	-150	678.420	679.830	679.689	USD -101,953	752.18 Profit of 10,874 on sale
2025-03-14	BUY	250	666.870	686.980	684.969	USD 171,242	753.38
2025-03-13	BUY	100	680.610	698.950	697.116	USD 69,712	754.42
2025-03-11	SELL	-280	718.160	747.700	744.746	USD -208,529	755.91 Profit of 3,126 on sale
2025-03-10	SELL	-250	744.830	748.290	747.944	USD -186,986	756.08 Profit of 2,033 on sale
2025-03-06	SELL	-250	698.440	701.000	700.744	USD -175,186	757.71 Profit of 14,242 on sale
2025-03-05	SELL	-100	687.150	692.790	692.226	USD -69,223	758.81 Profit of 6,659 on sale
2025-03-04	SELL	-450	675.490	697.460	695.263	USD -312,868	760.14 Profit of 29,193 on sale
2025-03-03	SELL	-235	684.870	704.640	702.663	USD -165,126	761.35 Profit of 13,792 on sale
2025-02-28	SELL	-145	698.740	708.580	707.596	USD -102,601	762.38 Profit of 7,943 on sale
2025-02-25	SELL	-200	723.470	739.000	737.447	USD -147,489	765.03 Profit of 5,517 on sale
2025-02-20	SELL	-100	696.020	703.140	702.428	USD -70,243	768.40 Profit of 6,598 on sale
2025-02-19	SELL	-300	685.660	688.670	688.369	USD -206,511	769.94 Profit of 24,470 on sale
2025-02-18	SELL	-150	680.000	689.950	688.955	USD -103,343	771.63 Profit of 12,402 on sale
2025-02-13	BUY	100	674.270	677.690	677.348	USD 67,735	777.50
2025-02-07	BUY	100	710.000	731.420	729.278	USD 72,928	785.77
2025-01-29	BUY	200	687.270	697.570	696.540	USD 139,308	802.55
2025-01-28	BUY	50	686.330	690.300	689.903	USD 34,495	805.61
2025-01-27	SELL	-5	684.710	698.450	697.076	USD -3,485	808.87 Profit of 559 on sale
2025-01-24	BUY	150	675.790	693.840	692.035	USD 103,805	812.57
2025-01-23	SELL	-2,100	694.640	696.190	696.035	USD -1,461,674	815.94 Profit of 251,800 on sale
2025-01-02	BUY	3,212	715.190	726.810	725.648	USD 2,330,781	818.90
2024-12-10	BUY	49	778.500	791.490	790.191	USD 38,719	820.13
2024-12-09	SELL	-343	788.000	800.990	799.691	USD -274,294	821.13 Profit of 7,354 on sale
2024-12-06	BUY	196	778.000	778.120	778.108	USD 152,509	822.52
2024-12-05	BUY	49	767.900	768.020	768.008	USD 37,632	824.34
2024-12-03	SELL	-196	749.570	770.000	767.957	USD -150,520	829.52 Profit of 12,066 on sale
2024-12-02	BUY	98	762.340	763.890	763.735	USD 74,846	832.00
2024-11-29	BUY	144	750.220	754.510	754.081	USD 108,588	835.15
2024-11-27	BUY	98	754.870	762.160	761.431	USD 74,620	841.84
2024-11-26	BUY	49	753.030	754.180	754.065	USD 36,949	845.70
2024-11-22	BUY	150	738.000	751.400	750.060	USD 112,509	855.41
2024-11-21	BUY	49	744.500	757.560	756.254	USD 37,056	860.96
2024-11-19	BUY	147	744.600	758.600	757.200	USD 111,308	873.95
2024-11-18	SELL	-507	762.000	762.700	762.630	USD -386,653	880.54 Profit of 59,780 on sale
2024-11-12	BUY	196	821.000	831.000	830.000	USD 162,680	884.26
2024-11-08	BUY	49	828.420	830.730	830.499	USD 40,694	892.43
2024-11-07	BUY	1,225	824.480	832.530	831.725	USD 1,018,863	897.66
2024-11-06	BUY	147	816.650	844.510	841.724	USD 123,733	904.41
2024-11-05	BUY	49	829.430	836.630	835.910	USD 40,960	911.23
2024-11-04	BUY	98	828.840	852.010	849.693	USD 83,270	919.47
2024-10-25	BUY	98	933.020	943.830	942.749	USD 92,389	950.28
2024-10-24	SELL	-98	928.900	952.020	949.708	USD -93,071	957.41 Profit of 755 on sale
2024-10-21	BUY	147	968.500	991.240	988.966	USD 145,378	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares NASDAQ 100 UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	NQSE(EUR) F
ETF Ticker	NQSE.DE(EUR) CXE